Ornidazole is an antibiotic used for the treatment of many bacterial and parasitic infections and was recently reported to suppress CD133+ melanoma CSCs by inhibiting the HH signaling pathway and hindering tumor growth in mouse models [359]. This evidence concerns the gene PROM1 and neoplasm.